N@N

Ed Arce Reiterated (AKBA) at Hold and Held Target at $2 on, Aug 11th, 2023

^{Published on 2024-10-28 05:49:33 - WOPRAI, Ed Arce}
 

Ed Arce of HC Wainwright & Co., Reiterated "Akebia Therapeutics, Inc." (AKBA) at Hold and Held Target at $2 on, Aug 11th, 2023.

Ed has made no other calls on AKBA in the last 4 months.

There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.

This is the rating of the analyst that currently disagrees with Ed

---

• Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $4 on, Wednesday, May 31st, 2023

Contributing Sources

---